Laura Karas, M.D., M.P.H., received her undergraduate degree magna cum laude from Harvard College. She received her medical degree from Baylor College of Medicine, where she earned academic distinction in the Basic Sciences and was awarded numerous scholarships. During medical school, Dr. Karas conducted independent research examining epidemiologic features of epilepsy patients served in the county health system's safety-net clinics. She also earned a Masters of Public Health in Health Policy and Management from the Harvard School of Public Health. As a medical student and trainee, Dr. Karas provided direct patient care in underserved community settings and in some of the nation’s largest medical centers. Dr. Karas has experience in health policy research, most recently with a multidisciplinary team focused on pharmaceutical drug pricing at the Johns Hopkins Bloomberg School of Public Health. Her work has been published in leading journals of various disciplines and medical specialties, including the American Journal of Managed Care, the American Journal of Public Health, and Hastings International and Comparative Law Review. In addition to being a licensed physician, Dr. Karas is registered to practice before the U.S. Patent and Trademark Office.
M.P.H. (Health Policy and Management), Harvard School of Public Health
M.D., Baylor College of Medicine
A.B., Harvard College, magna cum laude
Professional Licensure and Registration
U.S. Patent and Trademark Office
New York State Medical License
Texas Medical License
Laura Karas, Robin Feldman, Ge Bai, SoYeon Kang, and Gerard F. Anderson, Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation, 42 HASTINGS INT'L & COMP.L. Rev. 453 (2019).
Laura Karas, Gerard F. Anderson, and Robin Feldman, Pharmaceutical 'Pay-for-Delay' Reexamined: A Dwindling Practice or a Persistent Problem?, HASTINGS L.J. (forthcoming May 2020).